# Lactoferrin Use in (SARS-CoV-2) Management

> **NCT04860219** · NA · UNKNOWN · sponsor: **Zagazig University** · enrollment: 54 (estimated)

## Conditions studied

- Covid19

## Interventions

- **DIETARY_SUPPLEMENT:** Lactoferrin

## Key facts

- **NCT ID:** NCT04860219
- **Lead sponsor:** Zagazig University
- **Sponsor class:** OTHER_GOV
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-07-08
- **Primary completion:** 2020-09-18
- **Final completion:** 2021-04-30
- **Target enrollment:** 54 (ESTIMATED)
- **Last updated:** 2021-04-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04860219

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04860219, "Lactoferrin Use in (SARS-CoV-2) Management". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT04860219. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*